Sign in
4

Changes in Ownership

BridgeBio Pharma, Inc. Filed Acc 0000899243-20-032503

Chief Business Officer sold 784 shares at $30.04 ($23,549)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
HENDERSON MICHAEL THOMAS Chief Business Officer 2020-06-03 Sale −784 $30.04 $23,549 261,399 D: show line 1 in the form
Open-market sales · 784 sh · avg $30.04 · $23,549
Loading xslF345X03/doc4.xml…